Skip to main content

Many U.S. Adults Still Have Misconceptions About Skin Cancer Risk

Medically reviewed by Carmen Pope, BPharm. Last updated on March 26, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, March 26, 2025 -- About two-thirds of U.S. adults report no sunburns in the past year, with significant associations seen between the number of sunburns and sociodemographic factors, according to a study recently published online in the American Journal of Lifestyle Medicine.

Madison Etzel, from Florida Atlantic University in Boca Raton, and colleagues obtained information from the 2022 Health Information National Trends Survey 6 to explore sociodemographic characteristics, cancer risk perceptions, and behaviors surrounding sunburns. Associations between the number of sunburns and sociodemographic variables were examined. Data were included for 6,252 participants who were surveyed.

The researchers found that most respondents felt very confident or completely confident about their ability to take good care of their own health (44.0 and 27.3 percent, respectively). Most respondents were somewhat or slightly worried about getting cancer and few were extremely worried about getting cancer (28.3, 27.3, and 9.1 percent, respectively). Overall, 2.1, 30.3, and 67.6 percent reported experiencing more than six, one to five, and no sunburns, respectively, in the past 12 months. Significant associations were reported between the number of sunburns and age, gender, occupation status, marital status, education, Hispanic origin, race, and income level.

"Our study underscores the importance of raising awareness about skin cancer susceptibility as we found that all sociodemographic factors were significantly linked to the number of reported sunburns in the past year," Etzel said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Melphalan/Hepatic Delivery System Beneficial for Metastatic Uveal Melanoma

THURSDAY, April 24, 2025 -- For patients with unresectable metastatic uveal melanoma (mUM), the drug/device combination melphalan/hepatic delivery system (HDS) is efficacious and...

Circulating Tumor DNA Can ID Outcomes for Patients With Melanoma

WEDNESDAY, April 16, 2025 -- Droplet digital polymerase chain reaction (PCR) measurements of cell-free, circulating tumor DNA (ctDNA) can identify patients with melanoma and a...

Common Photosensitizing Drugs Increase Skin Cancer Risk

TUESDAY, April 1, 2025 -- Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.